Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-09 00:15 | 2021-12-07 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Semiconductors & Related Devices | SALE | $5.05 | 20,000 | $101,034 | 120,000 | -14.3% |
| 2021-02-24 01:02 | 2021-02-11 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Semiconductors & Related Devices | SALE | $11.48 | 165,000 | $1,894,646 | 44,500 | -78.8% |
| 2017-03-28 21:43 | 2017-03-27 | INO | INOVIO PHARMACEUTICALS, INC. | COLLINS MORTON | Director | Pharmaceutical Preparations | BUY | $6.25 | 21,300 | $133,189 | 50,000 | +74.2% |
| 2016-06-29 20:39 | 2016-06-28 | INO | INOVIO PHARMACEUTICALS, INC. | COLLINS MORTON | Director | Pharmaceutical Preparations | BUY | $9.13 | 10,000 | $91,309 | 142,291 | +7.6% |
| 2016-05-20 23:10 | 2016-05-18 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Semiconductors & Related Devices | BUY | $1.88 | 56,500 | $106,220 | 31,000 | +100.0% |
| 2016-04-18 21:20 | 2016-04-15 | INO | INOVIO PHARMACEUTICALS, INC. | COLLINS MORTON | Director | Pharmaceutical Preparations | BUY | $9.52 | 68,400 | $650,922 | 64,750 | +100.0% |
| 2014-08-22 20:21 | 2014-08-21 | INO | INOVIO PHARMACEUTICALS, INC. | COLLINS MORTON | Director | Pharmaceutical Preparations | BUY | $10.01 | 8,000 | $80,090 | 36,750 | +27.8% |
| 2014-08-21 19:49 | 2014-08-20 | INO | INOVIO PHARMACEUTICALS, INC. | COLLINS MORTON | Director | Pharmaceutical Preparations | BUY | $9.74 | 40,600 | $395,391 | 32,750 | +100.0% |
| 2013-11-14 22:34 | 2013-11-13 | INO | INOVIO PHARMACEUTICALS, INC. | COLLINS MORTON | Director | Pharmaceutical Preparations | BUY | $1.82 | 254,500 | $463,317 | 75,000 | +100.0% |
| 2013-01-16 22:35 | 2013-01-15 | INO | INOVIO PHARMACEUTICALS, INC. | COLLINS MORTON | Director | Pharmaceutical Preparations | BUY | $0.67 | 100,000 | $66,940 | 50,000 | +100.0% |
| 2011-08-25 01:27 | 2011-08-23 | INO | INOVIO PHARMACEUTICALS, INC. | COLLINS MORTON | Director | Pharmaceutical Preparations | BUY | $0.66 | 50,000 | $32,815 | 465,864 | +12.0% |
| 2011-08-15 18:41 | 2011-08-11 | INO | INOVIO PHARMACEUTICALS, INC. | COLLINS MORTON | Director | Pharmaceutical Preparations | BUY | $0.63 | 50,000 | $31,495 | 415,864 | +13.7% |
| 2011-06-30 00:29 | 2011-06-29 | INO | INOVIO PHARMACEUTICALS, INC. | COLLINS MORTON | Director | Pharmaceutical Preparations | BUY | $0.59 | 50,000 | $29,300 | 365,864 | +15.8% |
| 2011-06-27 23:08 | 2011-06-24 | INO | INOVIO PHARMACEUTICALS, INC. | COLLINS MORTON | Director | Pharmaceutical Preparations | BUY | $0.58 | 100,000 | $57,610 | 315,864 | +46.3% |
| 2009-01-09 23:14 | 2008-12-18 | SDIX | N/A | COLLINS MORTON | Director | Other | SALE | $0.81 | 20,000 | $16,204 | 305,062 | -6.2% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.